PHARMAC responds to Richard Milne on discounting health benefits and costs

N Z Med J. 2005 Jul 29;118(1219):U1600.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cost-Benefit Analysis
  • Drug Industry / economics*
  • Health Care Costs / trends*
  • Humans
  • National Health Programs / economics*
  • National Health Programs / trends*
  • New Zealand